Evidence map›Paper›PMID 41567667›Full record

ReviewFrontiers in medicine2025

Modulating rheology and bioactivity in dermal fillers: the emerging role of platelet-rich plasma (PRP).

Eduardo Anitua, Roberto Tierno, Mohammad Hamdan Alkhraisat

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eduardo AnituaBTI Biotechnology Institute, Vitoria, Spain.
Roberto TiernoBTI Biotechnology Institute, Vitoria, Spain.
Mohammad Hamdan AlkhraisatBTI Biotechnology Institute, Vitoria, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review explores the concept of dilutional rheomodulation in dermal fillers with the addition of platelet-rich plasma (PRP) and its potential to improve both aesthetic and regenerative outcomes. PRP is a biological product rich in growth factors and cytokines derived from the patient's own blood, which plays a significant role in tissue regeneration and healing. According to previous studies that utilized titrated aqueous solutions as solvents, it is hypothesized that incorporating PRP into different dermal filler formulations may be effective for modulating the rheological parameteres of dermal fillers while providing regenerative and immunomodulatory properties, potentially improving biocompatibility, injectability, distribution, and overall tissue integration as suggested by preliminary investigations. This combined approach may reduce severe adverse effects associated with filler injections while enhancing their biostimulatory effects. Moreover, PRP has been shown to stimulate collagen production and promote skin regeneration, which may extend the filler's longevity and improve skin texture and elasticity. Although early studies suggest positive outcomes, further clinical trials are needed to determine optimal dilution ratios, establish best practices, and assess long-term safety and efficacy. This review highlights the promising potential of PRP-filler combinations in advancing aesthetic procedures through the integration of immediate volumization with regenerative skin enhancement.

Indexed as

biostimulationdermal fillerdilutional rheomodulationplatelet-rich plasmaregenerative therapy

Identifiers

PMID41567667
PMCPMC12815725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.